This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lassmann, H. Search for Related Content PubMed PubMed Citation Articles by Lassmann, H. Social Bookmarking                   What's this?

Neuropathology in multiple sclerosis: new concepts

Institute of Neurology, University of Vienna, Austria

Multiple sclerosis lesions are characterized by inflammation, demyelination and a variable degree of axonal loss. The patterns of inflammation in MS lesions are compatible with a T-lymphocyte mediated immune reaction. The formation of demyelinated plaques, however, seem to require additional immunological mechanisms. In this review evidence is discussed for a pathogenetic role of demyelinating antibodies, toxic macrophage products, cytotoxic T-cells as well as metabolic disturbances of oligodendrocytes. It is suggested that the pathological heterogeneity regarding the patterns and extent of demyelination, remyelination and axonal loss may be the outcome of variable dominant immunopathogenetic mechanisms in different multiple sclerosis patients.

Key Words: Multiple sclerosis • pathology • demyelination • axon • oligodendrocyte

Multiple Sclerosis, Vol. 4, No. 3, 93-98 (1998)
DOI: 10.1177/135245859800400301


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Merkler, T. Ernsting, M. Kerschensteiner, W. Bruck, and C. Stadelmann A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination Brain, August 1, 2006; 129(8): 1972 - 1983. [Abstract] [Full Text] [PDF]

				B. Niland, K. Banki, W. E. Biddison, and A. Perl CD8+ T Cell-Mediated HLA-A*0201-Restricted Cytotoxicity to Transaldolase Peptide 168-176 in Patients with Multiple Sclerosis J. Immunol., December 15, 2005; 175(12): 8365 - 8378. [Abstract] [Full Text] [PDF]

				D. GR, T. DJ, C. M, R. A, D. CM, T. AJ, B. GJ, T. PS, and M. DH Estimation of the macromolecular proton fraction and bound pool T2 in multiple sclerosis Multiple Sclerosis, December 1, 2004; 10(6): 607 - 613. [Abstract] [PDF]

				J. A. Quandt, M. Baig, K. Yao, K. Kawamura, J. Huh, S. K. Ludwin, H.-J. Bian, M. Bryant, L. Quigley, Z. A. Nagy, et al. Unique Clinical and Pathological Features in HLA-DRB1*0401-restricted MBP 111-129-specific Humanized TCR Transgenic Mice J. Exp. Med., July 19, 2004; 200(2): 223 - 234. [Abstract] [Full Text] [PDF]

				E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF]

				C M Isbister, P J Mackenzie, D Anderson, N K Wade, and J Oger Co-occurrence of multiple sclerosis and myasthenia gravis in British C olumbia Multiple Sclerosis, December 1, 2003; 9(6): 550 - 553. [Abstract] [PDF]

				E. Molina-Holgado, J. M. Vela, A. Arevalo-Martin, G. Almazan, F. Molina-Holgado, J. Borrell, and C. Guaza Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling J. Neurosci., November 15, 2002; 22(22): 9742 - 9753. [Abstract] [Full Text] [PDF]

				E. Vitale, S. Cook, R. Sun, C. Specchia, K. Subramanian, M. Rocchi, D. Nathanson, M. Schwalb, M. Devoto, and C. Rohowsky-Kochan Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12 Hum. Mol. Genet., February 1, 2002; 11(3): 295 - 300. [Abstract] [Full Text] [PDF]

				F. Fazekas, S. Strasser-Fuchs, H. Kollegger, T. Berger, W. Kristoferitsch, H. Schmidt, C. Enzinger, M. Schiefermeier, C. Schwarz, B. Kornek, et al. Apolipoprotein E {epsilon}4 is associated with rapid progression of multiple sclerosis Neurology, September 11, 2001; 57(5): 853 - 857. [Abstract] [Full Text] [PDF]

				R. Meyer, R. Weissert, R. Diem, M. K. Storch, K. L. de Graaf, B. Kramer, and M. Bahr Acute Neuronal Apoptosis in a Rat Model of Multiple Sclerosis J. Neurosci., August 15, 2001; 21(16): 6214 - 6220. [Abstract] [Full Text] [PDF]

				B. Kornek, M. K. Storch, J. Bauer, A. Djamshidian, R. Weissert, E. Wallstroem, A. Stefferl, F. Zimprich, T. Olsson, C. Linington, et al. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis Brain, June 1, 2001; 124(6): 1114 - 1124. [Abstract] [Full Text] [PDF]

				I. Mader, U. Seeger, R. Weissert, U. Klose, T. Naegele, A. Melms, and W. Grodd Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis Brain, May 1, 2001; 124(5): 953 - 961. [Abstract] [Full Text] [PDF]

				K M Myhr, T Riise, C Vedeler, M W Nortvedt, M Gronning, R Midgard, and H I Nyland Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension Multiple Sclerosis, February 1, 2001; 7(1): 59 - 65. [Abstract] [PDF]

				S. Ropele, S. Strasser-Fuchs, M. Augustin, R. Stollberger, C. Enzinger, H.-P. Hartung, and F. Fazekas A Comparison of Magnetization Transfer Ratio, Magnetization Transfer Rate, and the Native Relaxation Time of Water Protons Related to Relapsing-remitting Multiple Sclerosis AJNR Am. J. Neuroradiol., November 1, 2000; 21(10): 1885 - 1891. [Abstract] [Full Text] [PDF]

				A. Stefferl, A. Schubart, M. Storch2, A. Amini, I. Mather, H. Lassmann, and C. Linington Butyrophilin, a Milk Protein, Modulates the Encephalitogenic T Cell Response to Myelin Oligodendrocyte Glycoprotein in Experimental Autoimmune Encephalomyelitis J. Immunol., September 1, 2000; 165(5): 2859 - 2865. [Abstract] [Full Text] [PDF]

				Y. Ge, R. I. Grossman, J. K. Udupa, L. Wei, L. J. Mannon, M. Polansky, and D. L. Kolson Brain Atrophy in Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis: Longitudinal Quantitative Analysis Radiology, March 1, 2000; 214(3): 665 - 670. [Abstract] [Full Text]

				A. Holz, B. Bielekova, R. Martin, and M. B. A. Oldstone Myelin-Associated Oligodendrocytic Basic Protein: Identification of an Encephalitogenic Epitope and Association with Multiple Sclerosis J. Immunol., January 15, 2000; 164(2): 1103 - 1109. [Abstract] [Full Text] [PDF]

				C H POLMAN, D H MILLER, W I MCDONALD, and A J THOMPSON Treatment recommendations for interferon-beta in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, November 1, 1999; 67(5): 561 - 564. [Full Text]

				R.-B. Lindert, C. G. Haase, U. Brehm, C. Linington, H. Wekerle, and R. Hohlfeld Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein Brain, November 1, 1999; 122(11): 2089 - 2100. [Abstract] [Full Text] [PDF]

				S. E. Baranzini, M. C. Jeong, C. Butunoi, R. S. Murray, C. C. A. Bernard, and J. R. Oksenberg B Cell Repertoire Diversity and Clonal Expansion in Multiple Sclerosis Brain Lesions J. Immunol., November 1, 1999; 163(9): 5133 - 5144. [Abstract] [Full Text] [PDF]

				M. Kremenchutzky, D. Cottrell, G. Rice, W. Hader, J. Baskerville, W. Koopman, and G. C. Ebers The natural history of multiple sclerosis: a geographically based study: 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation Brain, October 1, 1999; 122(10): 1941 - 1950. [Abstract] [Full Text] [PDF]

				P. S. Surensen Biological markers in body fluids for activity and progression in multiple sclerosis Multiple Sclerosis, August 1, 1999; 5(4): 287 - 290. [Abstract] [PDF]